Development of minimally differentiated acute myeloblastic leukemia with novel isochromosome 18p and antecedent aplastic anemia

Cancer Genetics and Cytogenetics
Y K KeungV Tonk

Abstract

We describe a case of acute myeloblastic leukemia with a novel isochromosome 18, i(18)(p10), preceded by aplastic anemia for six months. The patient is a cotton grower chronically exposed to pesticides. The significance of this chromosomal abnormality is unknown. The possible relationship to the preceding history of aplastic anemia and occupational pesticide exposure is speculated on. The possible mechanism of the association of acute leukemia and aplastic anemia is discussed.

References

May 7, 1992·The New England Journal of Medicine·S KojimaT Matsuyama
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Jan 1, 1988·Acta Haematologica·E OrlandiC Bernasconi
Feb 1, 1988·Blut·A TichelliB Speck
Apr 1, 1986·British Journal of Haematology·Y NakamoriY Oda
Nov 1, 1981·British Journal of Haematology·F BreatnachM F Greaves
Sep 15, 1981·Cancer·S W NeedlemanJ O Armitage
Jun 1, 1993·American Journal of Medical Genetics·D AbeliovichJ Zlotogora
Aug 1, 1993·American Journal of Medical Genetics·A J van EssenB Leegte
Jan 1, 1993·Cancer·Y H MatloubN K Ramsay

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.